↓ Skip to main content

Conversion of pericytes to neurons: a new guest at the reprogramming convention

Overview of attention for article published in Stem Cell Research & Therapy, January 2013
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Conversion of pericytes to neurons: a new guest at the reprogramming convention
Published in
Stem Cell Research & Therapy, January 2013
DOI 10.1186/scrt150
Pubmed ID
Authors

Emmanuel Nivet, Ignacio Sancho-Martinez, Juan Carlos Izpisua Belmonte

Abstract

ABSTRACT: Reprogramming strategies allow for the generation of virtually any cell type of the human body, which could be useful for cell-based therapy. Among the different reprogramming technologies available, direct lineage conversion offers the possibility to change the phenotype of a cell type to another one without pushing cells backwards to a plastic/proliferative stage. This approach has raised the possibility to apply a similar process in vivo in order to compensate for functional cell loss. Historically, the cerebral tissue is a prime choice for developing cell-based treatments. As local pericyte accumulation is observed after central nervous system injury, it can be reasoned that this cell type might be a good candidate for the conversion into new neurons in vivo. In this article, and by focusing on recent observations from Karow and colleagues demonstrating the possibility to convert human brain-derived pericytes into functional neurons, we present a brief overview of the state of the art and attempt to offer perspective as to how these interesting laboratory findings could be translated in the clinic.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Australia 1 4%
Unknown 22 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 35%
Student > Doctoral Student 3 13%
Researcher 3 13%
Student > Bachelor 2 9%
Student > Master 2 9%
Other 1 4%
Unknown 4 17%
Readers by discipline Count As %
Agricultural and Biological Sciences 9 39%
Neuroscience 4 17%
Medicine and Dentistry 3 13%
Immunology and Microbiology 1 4%
Biochemistry, Genetics and Molecular Biology 1 4%
Other 1 4%
Unknown 4 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 January 2013.
All research outputs
#20,191,579
of 22,708,120 outputs
Outputs from Stem Cell Research & Therapy
#2,035
of 2,410 outputs
Outputs of similar age
#250,008
of 282,323 outputs
Outputs of similar age from Stem Cell Research & Therapy
#15
of 15 outputs
Altmetric has tracked 22,708,120 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,410 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 282,323 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.